Louisiana State Employees Retirement System
INDV icon

Louisiana State Employees Retirement System’s Indivior Pharmaceuticals INDV Stock Holding History

Louisiana State Employees Retirement System’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Sell
53,400
-2,000
-4% -$72.6K 0.03% 570
2026
Q1 		$1.69M Sell
55,400
-1,800
-3% -$59.4K 0.03% 650
2025
Q4 		$2.05M Buy
+57,200
New +$1.75M 0.04% 525

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Oaktree Capital Management
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Louisiana State Employees Retirement System's INDV Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its Indivior Pharmaceuticals (INDV) stake by 3.6% in Q2 2026, selling an estimated $72.6K and leaving 53,400 shares worth $2.19M. The position accounts for 0.03% of the portfolio, ranked #570.

Louisiana State Employees Retirement System first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Louisiana State Employees Retirement System held 53,400 shares of Indivior Pharmaceuticals worth $2.19M as of Q2 2026.
  • Louisiana State Employees Retirement System sold 2,000 Indivior Pharmaceuticals shares in Q2 2026, an estimated $72.6K.
  • Indivior Pharmaceuticals made up 0.03% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #570 holding.
  • Louisiana State Employees Retirement System first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.